At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KVUE Kenvue Inc
Market Closed 05-03 16:00:00 EDT
19.20
+0.08
+0.42%
盘后19.20
+0.000.00%
19:54 EDT
High19.35
Low19.08
Vol15.94M
Open19.09
D1 Closing19.12
Amplitude1.44%
Mkt Cap36.76B
Tradable Cap33.21B
Total Shares1.91B
T/O306.36M
T/O Rate0.92%
Tradable Shares1.73B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
U.S. IPO Weekly Recap: Viking Trades Up After Completing The Year's Largest US IPO To Date
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.